About
Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (2)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
311
By Phase
PHASE1: 3PHASE1/PHASE2: 1
By Status
RECRUITING: 2NOT_YET_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07126704Lead Sponsor
A Phase 1, SAD and MAD to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral FB-101 in Healthy Adult Male Subjects
PHASE1Not yet recruiting
72 participants
Started: Nov 30, 2025 · Completed: Jun 30, 2027
NCT05995782Lead Sponsor
A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418
PHASE1Recruiting
64 participants
Started: Dec 20, 2023 · Completed: Dec 31, 2024
NCT05761223Lead Sponsor
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
PHASE1/PHASE2Recruiting
151 participants
Started: Dec 13, 2023 · Completed: Oct 31, 2026
NCT04165837Lead Sponsor
Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects
PHASE1Completed
24 participants
Started: Oct 14, 2019 · Completed: Jul 14, 2022
Locations (1)
Headquarters
Gyeonggi, Korea
Map
Loading map...